PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients

BACKGROUND: Biomarkers that facilitate the prediction of disease recurrence in head and neck squamous cell carcinoma (HNSCC) may enable physicians to personalize treatment. In the current study, DNA promoter methylation of programmed cell death 1 (PDCD1, PD-1) was evaluated as a prognostic biomarker...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Goltz, Diane, Gevensleben, Heidrun, Dietrich, Joern, Schroeck, Friederike, de Vos, Luka, Droege, Freya, Kristiansen, Glen, Schroeck, Andreas, Landsberg, Jennifer, Bootz, Friedrich, Dietrich, Dimo
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5522222/
https://ncbi.nlm.nih.gov/pubmed/28487502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17354
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados